ArticleBMC urology2014

Changes in prostaglandin E2 in patients with idiopathic overactive bladder syndrome after botulinum toxin type A treatment: is there a clinical benefit?

Axel Hegele et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.